FDA Increases OTC Monograph User Fees by 19 Percent for Fiscal 2022 Post author:PacConAdmin Post published:March 14, 2022 Post category:Drug Industry Daily The FDA has released its over-the-counter (OTC) monograph drug user fees for fiscal 2022. Source: Drug Industry Daily You Might Also Like FDA to Adopt ICH E9 Addendum on Clinical Trials Analyses October 30, 2017 Pfizer Launches Its Own Challenge to Genentech’s Herceptin Patent, Following Celltrion, Mylan June 2, 2017 Japanese API Maker Draws FDA Warning for Data Integrity Failures July 31, 2018
Pfizer Launches Its Own Challenge to Genentech’s Herceptin Patent, Following Celltrion, Mylan June 2, 2017